Immutep Announces KOL Event Focused on Eftilagimod Alpha in Non-Small Cell Lung Cancer and Head Neck Squamous Cell Carcinoma - Yahoo Finance

PRRUF Stock  USD 0.20  0.00  0.00%   
Roughly 62% of Immutep's investor base is looking to short. The analysis of overall sentiment of trading Immutep Limited pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Immutep's historical and current headlines, can help investors time the market. In addition, many technical investors use Immutep Limited stock news signals to limit their universe of possible portfolio assets.
Immutep pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immutep daily returns and investor perception about the current price of Immutep Limited as well as its diversification or hedging effects on your existing portfolios.
  
Immutep Announces KOL Event Focused on Eftilagimod Alpha in Non-Small Cell Lung Cancer and Head Neck Squamous Cell Carcinoma Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Immutep Fundamental Analysis

We analyze Immutep's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

Immutep is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Immutep Limited Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Immutep pink sheet to make a market-neutral strategy. Peer analysis of Immutep could also be used in its relative valuation, which is a method of valuing Immutep by comparing valuation metrics with similar companies.

Peers

Immutep Related Equities

CDTXCidara Therapeutics   5.73   
0%
65.0%
ZURAZura Bio   3.64   
0%
41.0%
ALXOAlx Oncology   2.11   
0%
24.0%
APLTApplied Therapeutics   0.88   
0%
10.0%
ENVBEnveric Biosciences   0.83   
0%
9.0%
OLMAOlema Pharmaceuticals   0.45   
0%
5.0%
VRDNViridian Therapeutics   0.78   
8.0%
0%
AADIAadi Bioscience   0.83   
9.0%
0%
ZNTLZentalis Pharmaceuticals   1.28   
14.0%
0%
GPCRStructure Therapeutics   1.45   
16.0%
0%
CTMXCytomX Therapeutics   1.79   
20.0%
0%
ALVRAllovir   2.17   
24.0%
0%
SLNSilence Therapeutics   2.27   
25.0%
0%
CYTKCytokinetics   3.16   
35.0%
0%
CGEMCullinan Oncology   3.52   
40.0%
0%
CRNXCrinetics Pharmaceuticals   3.52   
40.0%
0%
IMMXImmix Biopharma   4.23   
48.0%
0%
ADCTADC Therapeutics   4.55   
51.0%
0%
ELEVElevation Oncology   5.19   
59.0%
0%
SANASana Biotechnology   7.35   
83.0%
0%
DSGNDesign Therapeutics   8.79   
100.0%
0%

Complementary Tools for Immutep Pink Sheet analysis

When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data